
Biotechnology • Pharmaceuticals • Healthcare Insurance
Akero Therapeutics is a company pioneering novel therapies to transform the lives of people living with serious metabolic diseases. Their flagship program, Efruxifermin (EFX), is aimed at treating metabolic dysfunction-associated steatohepatitis (MASH) and is currently undergoing multiple clinical trials. Akero is committed to advancing medicine in the field of metabolic diseases and has a strong focus on research, development, and clinical studies.
11 - 50 employees
Founded 2017
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
September 10
Provide QA oversight for clinical trials and global pharmacovigilance at Akero Therapeutics developing treatments for metabolic diseases.
September 10
Senior QA lead ensuring CDMO/CTL compliance and batch release for Akero Therapeutics biologics. Drives regulatory inspection readiness and data integrity in a virtual company model.
🏄 California – Remote
💵 $135k - $145k / year
⏰ Full Time
🟠 Senior
🔴 Lead
🔧 QA Engineer (Quality Assurance)